Estrogen Receptor Positive/Progesterone Receptor Negative Breast Carcinomas: A Subgroup Deserves Particular Interest

Gucin Z., GECER M. O., Buyukpinarbasili N., SONMEZ C., Ersoy Y. E., MUSLUMANOGLU M.

BEZMIALEM SCIENCE, vol.3, no.2, pp.29-32, 2015 (ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 3 Issue: 2
  • Publication Date: 2015
  • Journal Indexes: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
  • Page Numbers: pp.29-32
  • Bezmialem Vakıf University Affiliated: Yes


Objective: Breast carcinomas positive for the estrogen receptor (ER+) but negative for the progesterone receptor (PR-) have unfavorable prognostic features and are resistant to tamoxifen therapy. The goal of this study was to highlight the significance of PR-breast carcinomas.